Domestic Drug Makers’ Major Products See Sharp Declines in 1st Half; Sales of Aricept, Lipitor Down 30%

Major domestic drug makers reported sharp declines in sales of their long-listed products due to competition from generics and reductions in NHI prices in their semiannual settlements of accounts for FY2012 (April-September 2012). Sales of Eisai’s Alzheimer’s disease treatment Aricept...read more